Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 500.60
+15.40 (3.17%)
Nov 4, 2025, 4:59 PM CET
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 35.24 billion as of November 4, 2025. Its market cap has decreased by -37.04% in one year.
Market Cap
35.24B
Enterprise Value
19.06B
Revenue
9.11B
Ranking
n/a
PE Ratio
5.34
Stock Price
500.60
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 35.24B, an increase of 2,407.15%. That is a compound annual growth rate of 24.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 34.16B | -32.42% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | 8.77B | 3.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.40T |
| Coloplast | 131.86B |
| Genmab | 113.14B |
| ALK-Abelló | 47.20B |
| Demant | 45.88B |
| H. Lundbeck | 44.65B |
| Ambu A/S | 26.83B |
| Bavarian Nordic | 18.70B |